PROK Stock Price - ProKidney Corp. logo

PROK Stock Price

ProKidney Corp.

$1.05
+$0.00(+0.48%)
26
Overall
40
Value
18
Tech
21
Quality
How is this score calculated?
Market Cap
$315.99M
Volume
1.08M
52W Range
$0.87 - $2.65
Target Price
$6.50

PROK stock price is $1.05 (+0.48% on the day), giving ProKidney Corp. a market cap of $315.99M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.

PROK Stock Overview

Price
$1.04
Previous close
$1.04
Open
$1.07
Market cap
$315.99M
52-week range
$0.87 - $2.65
1-year price target
$6.50
Sector
Healthcare
Industry
Biotechnology
Exchange
Nasdaq
MarketXLS Rank
26

About ProKidney Corp.

ProKidney Corp., a clinical-stage biotechnology company, develops a cell therapy platform for the treatment of multiple chronic kidney diseases in the United States. Its lead product candidate, rilparencel, includes autologous selected renal cells (SRC) in Phase 3 and Phase 2 clinical studies in subjects with moderate to severe chronic kidney disease and diabetes. The company also develops a cryopreserved version of rilparencel that allows for long-term product preservation to be used in Phase 2 and 3 trials of rilparencel. ProKidney Corp. founded in 2015 and is based in Winston-Salem, North Carolina.

ABCD
1SymbolPriceChangeVol
2PROK$1.05+0.5%1.08M
3
4
5
6

Get ProKidney Corp. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.